Legend Biotech Corporation
NASDAQ: LEGN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ying Huang
- Employees
- 2,900
- Headquarters
- Somerset, United States
- IPO year
- 2020
- Market cap
- $5.5B
- Website
- https://www.legendbiotech.com
Loading LEGN…
Loading profile data…Frequently asked questions about LEGN
What does Legend Biotech Corporation (LEGN) do?
Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antige...
Where does LEGN trade?
Legend Biotech Corporation (LEGN) trades on the NASDAQ.
What sector is LEGN in?
Legend Biotech Corporation (LEGN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Legend Biotech Corporation?
Ying Huang is the chief executive officer of Legend Biotech Corporation (LEGN).
Where is Legend Biotech Corporation headquartered?
Legend Biotech Corporation is headquartered in United States.
Does LEGN pay a dividend?
Legend Biotech Corporation (LEGN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LEGN go public?
Legend Biotech Corporation (LEGN) completed its initial public offering in 2020.